Last reviewed 2026-04-22 · How we verify

Conventional medical treatment

Conventional medical treatment refers to standard, evidence-based therapeutic approaches using established drugs and interventions rather than experimental or novel therapies.

At a glance

Mechanism of action

Conventional medical treatment encompasses the use of FDA-approved medications, surgical procedures, and established clinical protocols that have demonstrated safety and efficacy through rigorous testing and long-term clinical use. These treatments are typically first-line options for various diseases and conditions, representing the standard of care in medical practice.

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

• Venetoclax for the Treatment of Patients With Relapsed Hairy Cell Leukemia (PHASE2)
• A Study to Compare the Administration of Pembrolizumab After Surgery Versus Administration Both Before and After Surgery for High-Risk Melanoma (PHASE2)
• Testing the Combination of ZEN003694 and Nivolumab With or Without Ipilimumab in Solid Tumors (PHASE1)
• Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tumors (PHASE3)
• Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer (PHASE3)
• Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial) (PHASE2)
• A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal Carcinoma (NPC) (PHASE2)
• Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the Treatment of Recurrent Ovarian and Endometrial Cancer (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.